A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT04968574 · COMPLETED
Trial details
- NCT number
- NCT04968574
- Sponsor
- Endeavor Biomedicines, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-26
- Primary completion
- 2023-11-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.